Patent | Date |
---|
Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Grant 11,244,744 - Bell , et al. February 8, 2 | 2022-02-08 |
Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor Grant 11,031,102 - Bell , et al. June 8, 2 | 2021-06-08 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20200392216 - BELL; Leonard ;   et al. | 2020-12-17 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 10,703,809 - Bell , et al. | 2020-07-07 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20200199211 - BELL; Leonard ;   et al. | 2020-06-25 |
Methods For Treating Complement-associated Disorders App 20200140531 - ROTHER; Russell P. ;   et al. | 2020-05-07 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 10,590,189 - Bell , et al. | 2020-03-17 |
Method For Treating A Patient In Compliance With Vaccination With Eculizumab Or An Eculizumab Variant App 20180142010 - BELL; Leonard ;   et al. | 2018-05-24 |
Methods For Treating Complement-associated Disorders App 20170369562 - ROTHER; Russell P. ;   et al. | 2017-12-28 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20170349652 - BELL; Leonard ;   et al. | 2017-12-07 |
Risk Evaluation And Management Strategy Involving Patient Follow-ups Relating To The Use Or Discontinuation Of A Complement Inhibitor App 20170277835 - BELL; Leonard ;   et al. | 2017-09-28 |
Methods for treating complement-associated disorders Grant 9,771,418 - Rother , et al. September 26, 2 | 2017-09-26 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,732,149 - Bell , et al. August 15, 2 | 2017-08-15 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,725,504 - Bell , et al. August 8, 2 | 2017-08-08 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant 9,718,880 - Bell , et al. August 1, 2 | 2017-08-01 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20170015741 - BELL; Leonard ;   et al. | 2017-01-19 |
Methods For Treating Complement-associated Disorders App 20170015740 - Rother; Russell P. ;   et al. | 2017-01-19 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20160376355 - BELL; Leonard ;   et al. | 2016-12-29 |
Methods For Treating Complement-associated Disorders App 20160355579 - Rother; Russell P. ;   et al. | 2016-12-08 |
Methods For Treating Complement-associated Disorders App 20160355580 - ROTHER; Russell P. ;   et al. | 2016-12-08 |
Methods And Compositions For Treating Complement-associated Disorders App 20160319004 - Rother; Russell P. ;   et al. | 2016-11-03 |
Methods and compositions for treating complement-associated disorders Grant 9,447,176 - Rother , et al. September 20, 2 | 2016-09-20 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20160244516 - BELL; Leonard ;   et al. | 2016-08-25 |
Risk Evaluation And Management Strategy Involving Patient Follow-ups Relating To The Use Or Discontinuation Of A Complement Inhibitor App 20160140298 - BELL; Leonard ;   et al. | 2016-05-19 |
Methods Of Distributing Complement-inhibiting Drugs To Patients Receiving A Complement Inhibitor App 20130246083 - Bell; Leonard | 2013-09-19 |
Method Of Treating Hemolytic Disease App 20120308559 - Bell; Leonard ;   et al. | 2012-12-06 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20120237515 - Bell; Leonard ;   et al. | 2012-09-20 |
Methods And Compositions For Treating Complement-associated Disorders App 20120225056 - Rother; Russell P. ;   et al. | 2012-09-06 |
Method Of Treating Hemolytic Disease App 20110086040 - Bell; Leonard ;   et al. | 2011-04-14 |
Method Of Treating Hemolytic Disease App 20100068202 - Bell; Leonard ;   et al. | 2010-03-18 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement App 20090220508 - Bell; Leonard ;   et al. | 2009-09-03 |
Methods for reducing morality associated with acute myocardial infarction Grant 7,361,339 - Bell April 22, 2 | 2008-04-22 |
Methods of treating hemolytic anemia App 20070116710 - Bell; Leonard ;   et al. | 2007-05-24 |
Method of treating hemolytic disease App 20050191298 - Bell, Leonard ;   et al. | 2005-09-01 |
Method of treating hemolytic disease App 20050169921 - Bell, Leonard ;   et al. | 2005-08-04 |
Universal donor cells Grant 6,916,654 - Sims , et al. July 12, 2 | 2005-07-12 |
Methods for reducing mortality associated with acute myocardial infarction App 20040219147 - Bell, Leonard | 2004-11-04 |
Method of prophylaxis against large myocardial infarctions App 20040081619 - Bell, Leonard | 2004-04-29 |
Method of improving cognitive function App 20030049260 - Bell, Leonard | 2003-03-13 |
Method of prophylaxis against large myocardial infractions App 20020094332 - Bell, Leonard | 2002-07-18 |
Universal donor cells Grant 6,100,443 - Sims , et al. August 8, 2 | 2000-08-08 |
Universal donor cells Grant 5,705,732 - Sims , et al. January 6, 1 | 1998-01-06 |
Genetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activity Grant 5,336,615 - Bell , et al. August 9, 1 | 1994-08-09 |
Process for producing a quick-cooking rice Grant 4,338,344 - Brooks , et al. July 6, 1 | 1982-07-06 |